Tanespimycin in Treating Young Patients With Recurrent or Refractory Leukemia or Solid Tumors

Conditions

• Childhood Chronic Myelogenous Leukemia
• Childhood Desmoplastic Small Round Cell Tumor
• Disseminated Neuroblastoma
• Metastatic Childhood Soft Tissue Sarcoma
• Metastatic Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor
• Metastatic Osteosarcoma
• Previously Treated Childhood Rhabdomyosarcoma
• Recurrent Childhood Acute Lymphoblastic Leukemia
• Recurrent Childhood Acute Myeloid Leukemia
• Recurrent Childhood Rhabdomyosarcoma
• Recurrent Childhood Soft Tissue Sarcoma
• Recurrent Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor
• Recurrent Neuroblastoma
• Recurrent Osteosarcoma

Interventions

• DRUG: tanespimycin
• OTHER: pharmacological study
• OTHER: laboratory biomarker analysis

Sponsor

National Cancer Institute (NCI)